EAGLE + ANTERIOR CERVICAL PLATE SYSTEM

K070994 · Depuy Spine, Inc. · KWQ · May 9, 2007 · Orthopedic

Device Facts

• Record ID: K070994
• Device Name: EAGLE + ANTERIOR CERVICAL PLATE SYSTEM
• Applicant: Depuy Spine, Inc.
• Product Code: KWQ · Orthopedic
• Decision Date: May 9, 2007
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3060
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The EAGLE + Anterior Cervical Plate System is intended for anterior cervical intervertebral body fixation. These systems are indicated for patients in which stability is desired following anterior cervical fusion for the indications listed below. The intended levels for treatment range from C2 to T1. Indications include symptomatic cervical spondylosis, trauma, fracture, post-traumatic kyphosis or lordosis, tumor, degenerative disc disease (defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies), reoperation for failed fusion, or instability following surgery for the above indications.

Device Story

EAGLE + Anterior Cervical Plate System consists of titanium alloy plates and screws for anterior cervical intervertebral body fixation. Used by surgeons in clinical settings to provide spinal stability following fusion procedures (levels C2-T1). Device components are implanted to address conditions such as trauma, degenerative disc disease, and tumors. System includes manual surgical instruments. Benefit is stabilization of cervical spine segments.

Clinical Evidence

Bench testing only.

Technological Characteristics

Implant grade titanium alloy (ASTM F-136). System comprises plates and screws. Manual surgical instruments included. No software or electronic components.

Indications for Use

Indicated for patients requiring anterior cervical intervertebral body fixation (levels C2-T1) for stability following fusion. Conditions include symptomatic cervical spondylosis, trauma, fracture, post-traumatic kyphosis/lordosis, tumor, degenerative disc disease, re-operation for failed fusion, or post-surgical instability.

Regulatory Classification

Identification

A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.

Predicate Devices

• EAGLE™ Anterior Cervical Plate System (K040197)

Submission Summary (Full Text)

{0}------------------------------------------------

K070994
Page 1 of 2

## IX. 510(k) Summary

| SUBMITTER: | DePuy Spine, Inc.<br>325 Paramount Drive<br>Raynham, MA 02780 | MAY - 9 2007 |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|
| CONTACT PERSON: | Frank S. Jurczak | |
| DATE PREPARED: | April 6, 2007 | |
| CLASSIFICATION NAME: | Spinal Intervertebral Body Fixation Orthosis | |
| PROPRIETARY NAME: | EAGLE™ + Anterior Cervical Plate System | |
| PREDICATE DEVICES: | EAGLE™ Anterior Cervical Plate System<br>(K040197) | |
| DEVICE DESCRIPTION: | The EAGLE + Anterior Cervical Plate System consists<br>of an assortment of plates and screws. | |
| | The EAGLE + Anterior Cervical Plate System also<br>contains Class 1 manual surgical instruments and<br>cases that are considered exempt from premarket<br>notification. | |
| INTENDED USE: | The indications for use for the modified devices<br>described in this submission are the same as those<br>for the previously cleared EAGLE Anterior Cervical<br>Plate System (K040197). The indications are as<br>follows: | |
| | The EAGLE + Anterior Cervical Plate System is<br>intended for anterior cervical intervertebral body<br>fixation. These systems are indicated for patients in<br>which stability is desired following anterior cervical<br>fusion for the indications listed below. The intended<br>levels for treatment range from C2 to T1. | |
| | Indications include symptomatic cervical spondylosis,<br>trauma, fracture, post-traumatic kyphosis or lordosis,<br>tumor, degenerative disc disease (defined as<br>discogenic pain with degeneration of the disc | |

{1}------------------------------------------------

K070994
Page 2 of 2

confirmed by history and radiographic studies), reoperation for failed fusion, or instability following surgery for the above indications.

- MATERIALS: Manufactured from ASTM F-136 implant grade titanium alloy.
PERFORMANCE DATA:

Performance data were submitted to characterize the EAGLE + Anterior Cervical Plate System.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with its wings spread, surrounded by the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. The eagle is depicted in a simple, black line drawing, and the text is also in black.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DePuy Spine, Incorporated c/o Mr. Frank Jurczak Regulatory Affairs Associate II 325 Paramount Drive Raynham, MA 02767

MAY - 9 2007

Re: K070994

Trade/Device Name: EAGLE + Anterior Cervical Plate System Regulation Number: 21 CFR §888.3060 Regulation Name: Spinal Intervertebral Body Fixation Orthosis Regulatory Class: Class II Product Code: KWQ Dated: April 06, 2007 Received: April 09, 2007

Dear Mr. Jurczak:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

## Page 2 - Mr. Frank Jurczak

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Barbine Buent

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

EAGLE™ + Anterior Cervical Plate System Device Name:

## Indications For Use:

The EAGLE™ + Anterior Cervical Plate System is intended for anterior cervical intervertebral body fixation. This system is indicated for patients in which stability is desired following anterior cervical fusion for the indications listed below. The intended levels for treatment range from C2 to T1.

Indications include symptomatic cervical spondylosis, trauma, fracture, posttraumatic kyphosis or lordosis, tumor, degenerative disc disease (defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies), re-operation for failed fusion, or instability following surgery for the above indications.

X Prescription Use: (Per 21 CFR 801.109)

(Please do not write below this line - continue on another page if needed)

Concurrence of CDRH, Office of Device Evaluation (ODE)

barbare bucm

(Division Sign-Off) Division of General. Restorative, and Neurological Devices

510(k) Number K070994